Roche’s Analyst Event following ASRS 2020

Monday, 27 July 2020 at 16:30 CEST

Video Webcast replay

Downloads

Presentation

Additional information

Invitation

Related links

Half Year Results 2020
Presentations from recent IR events

Investor updates

Published on: 6 August 2020

Roche provides update on Phase III study of Tecentriq in combination with paclitaxel for people with metastatic triple-negative breast cancer

Published on: 5 August 2020

Roche announces FDA authorisation for the first Epstein-Barr virus quantitative test on the cobas 6800/8800 Systems to improve care for transplant patients

Published on: 3 August 2020

Rozlytrek, Roche’s first tumour-agnostic therapy, approved in Europe for people with NTRK fusion-positive solid tumours and for people with ROS1-positive advanced non-small cell lung cancer

IR events

12August

UBS Genomics Summit (virtual event)

12 - 13 August 2020 (PST)

Laguna Beach, US

add to calendar

27August

J.P. Morgan CEO Conference Call Series

(CEST)

Basel, Switzerland

add to calendar

27August

Global C-Suite Forum, Pan Asia (virtual event)

(CEST)

Basel, Switzerland

add to calendar

Share price

Latest annual report

Annual Report 2019 Highlights

How medicines are making an impact in the lives of patients

Finance information tool

Pipeline

Pipeline

Get up-to-date information about our pipeline.

Roche R&D

Genentech Biooncology

Diagnostics

Diagnostics overview

Get an introduction to our Diagnostics business.

Sustainability

Sustainability download center

Sustainability at Roche

Non-financial reporting

Dividend and total return

Dividend calendar

Timetable for the payment of the 2019 dividend

Total return center

Investor tool providing analysis of total returns

Frequently asked questions

FAQ

Get answers to frequently asked questions

US investors

How to invest

Contact